PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass
Open Access
- 30 October 2012
- journal article
- Published by Springer Nature in BMC Anesthesiology
- Vol. 12 (1) , 27
Abstract
Enhanced bleeding remains a serious problem after cardiac surgery, and fibrinolysis is often involved. We speculate that lower plasma concentrations of plasminogen activator inhibitor – 1 (PAI-1) preoperatively and tissue plasminogen activator/PAI-1 (t-PA/PAI-1) complex postoperatively might predispose for enhanced fibrinolysis and increased postoperative bleeding.Keywords
This publication has 31 references indexed in Scilit:
- Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood lossInternational Journal of Molecular Medicine, 2010
- PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery – pilot studyEuropean Journal of Anaesthesiology, 2009
- Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized studyCoronary Artery Disease, 2009
- Plasminogen activator inhibitor type 1 deficiencyHaemophilia, 2008
- Postoperative Bleeding in Cardiac SurgeryAnesthesiology, 2008
- Coagulopathy After Cardiac Surgery May Be Influenced by a Functional Plasminogen Activator Inhibitor PolymorphismAnesthesia & Analgesia, 2007
- Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control studyJournal of Cardiothoracic Surgery, 2007
- Review and application of serine protease inhibition in coronary artery bypass graft surgeryAmerican Journal of Health-System Pharmacy, 2005
- Genetic factors contribute to bleeding after cardiac surgeryJournal of Thrombosis and Haemostasis, 2005
- Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapyBlood Coagulation & Fibrinolysis, 2003